Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers.
Vidal L, Dlamini Z, Qian S, Rishi P, Karmo M, Joglekar N, Abedin S, Previs RA, Orbegoso C, Joshi C, Azim HA, Karkaria H, Harris M, Mehrotra R, Berraondo M, Werutsky G, Gupta S, Niikura N, Chico I, Saini KS. Vidal L, et al. Among authors: niikura n. ESMO Open. 2024 May;9(5):103373. doi: 10.1016/j.esmoop.2024.103373. Epub 2024 May 7. ESMO Open. 2024. PMID: 38718705 Free PMC article. Review.
Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.
Takeshita T, Iwamoto T, Niikura N, Watanabe K, Kikawa Y, Kobayashi K, Iwakuma N, Okamura T, Tada H, Ozaki S, Okuno T, Toh U, Yamamoto Y, Tsuneizumi M, Ishiguro H, Masuda N, Saji S. Takeshita T, et al. Among authors: niikura n. ESMO Open. 2024 Apr;9(4):102385. doi: 10.1016/j.esmoop.2024.102385. Epub 2024 Feb 21. ESMO Open. 2024. PMID: 38387111 Free PMC article.
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment.
Hanamura T, Yokoyama K, Kitano S, Kagamu H, Yamashita M, Terao M, Okamura T, Kumaki N, Hozumi K, Iwamoto T, Honda C, Kurozumi S, Richer JK, Niikura N. Hanamura T, et al. Among authors: niikura n. Cancer Immunol Immunother. 2024 Feb 13;73(3):42. doi: 10.1007/s00262-024-03629-1. Cancer Immunol Immunother. 2024. PMID: 38349455 Free PMC article.
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry.
Iwamoto T, Kumamaru H, Niikura N, Sagara Y, Miyashita M, Konishi T, Sanuki N, Tanakura K, Nagahashi M, Hayashi N, Yoshida M, Watanabe C, Kinukawa N, Toi M, Saji S. Iwamoto T, et al. Among authors: niikura n. Breast Cancer. 2024 Mar;31(2):185-194. doi: 10.1007/s12282-024-01545-x. Epub 2024 Feb 6. Breast Cancer. 2024. PMID: 38319565
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan.
Sagara Y, Kumamaru H, Niikura N, Miyashita M, Konishi T, Iwamoto T, Sanuki N, Tanakura K, Nagahashi M, Hayashi N, Yoshida M, Kinukawa N, Watanabe C, Toi M, Saji S. Sagara Y, et al. Among authors: niikura n. Breast Cancer. 2024 Mar;31(2):179-184. doi: 10.1007/s12282-023-01532-8. Epub 2024 Jan 5. Breast Cancer. 2024. PMID: 38180641
Annual report of the Japanese Breast Cancer Registry for 2019.
Miyashita M, Kumamaru H, Niikura N, Sagara Y, Konishi T, Iwamoto T, Sanuki N, Tanakura K, Nagahashi M, Hayashi N, Yoshida M, Watanabe C, Kinukawa N, Toi M, Saji S. Miyashita M, et al. Among authors: niikura n. Breast Cancer. 2024 Jan;31(1):16-23. doi: 10.1007/s12282-023-01526-6. Epub 2023 Dec 4. Breast Cancer. 2024. PMID: 38044372
BRCA1/2 reversion mutations in a pan-cancer cohort.
Nakamura K, Hayashi H, Kawano R, Ishikawa M, Aimono E, Mizuno T, Kuroda H, Kojima Y, Niikura N, Kawanishi A, Takeshita K, Suzuki S, Ueno S, Okuwaki K, Sasaki J, Yamaguchi M, Masuda K, Chiyoda T, Yamagami W, Okada C, Nohara S, Tanishima S, Nishihara H. Nakamura K, et al. Among authors: niikura n. Cancer Sci. 2024 Feb;115(2):635-647. doi: 10.1111/cas.16033. Epub 2023 Dec 1. Cancer Sci. 2024. PMID: 38041241 Free PMC article.
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer.
Iwamoto T, Niikura N, Watanabe K, Takeshita T, Kikawa Y, Kobayashi K, Iwakuma N, Okamura T, Tada H, Ozaki S, Okuno T, Toh U, Yamamoto Y, Tsuneizumi M, Ishiguro H, Masuda N, Saji S. Iwamoto T, et al. Among authors: niikura n. Breast Cancer Res Treat. 2024 Jan;203(2):225-234. doi: 10.1007/s10549-023-07144-2. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37875670
121 results